期刊
DIABETES
卷 67, 期 10, 页码 1923-1931出版社
AMER DIABETES ASSOC
DOI: 10.2337/db18-0537
关键词
-
资金
- National Institutes of Health
- JDRF
- Lilly
- Boehringer Ingelheim
- GSK
- Regeneron
- Merck
- ONO Pharma
- Celgene
The American Diabetes Association convened a research symposium, Epigenetics and Epigenomics: Implications for Diabetes and Obesity on 17-19 November 2017. International experts in genetics, epigenetics, computational biology, and physiology discussed the current state of understanding of the relationships between genetics, epigenetics, and environment in diabetes and examined existing evidence for the role of epigenetic factors in regulating metabolism and the risk of diabetes and its complications. The authors summarize the presentations, which highlight how the complex interactions between genes and environment may in part be mediated through epigenetic changes and how information about nutritional and other environmental stimuli can be transmitted to the next generation. In addition, the authors present expert consensus on knowledge gaps and research recommendations for the field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据